Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Newer GLP-1 options Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, is in late-stage clinical trials and showing even greater weight loss potential than current options
CJC-1295 (Mod GRF 1-29) is considered to be an agonist to the receptors for the native Growth Hormone-Releasing Hormone (GHRH)
GLP-1 receptor agonists like semaglutide (Wegovy), tirzepatide (Zepbound), and liraglutide (Saxenda) work through multiple mechanisms to improve blood sugar control and promote weight loss
Zhang D
US$ 26.53
US$ 21.80
US$ 21.59
US$ 29.49
US$ 28.58
US$ 26.34
US$ 22.22
US$ 29.75
US$ 20.43
US$ 23.26
US$ 26.71
US$ 28.73
US$ 29.66
US$ 28.83
